Supplementary Data 6 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation

Supplementary Data 6 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation

<p>Supplementary Data 6: Association between individual metabolites and radiation survival</p>

-д хадгалсан:

Номзүйн дэлгэрэнгүй
Үндсэн зохиолч:	Priyanka Gopal (15050862) (author)
Бусад зохиолчид:	Brian D. Yard (15050865) (author), Aaron Petty (15050868) (author), Jessica C. Lal (15050871) (author), Titas K. Bera (15050874) (author), Trung Q. Hoang (15050877) (author), Alexandru D. Buhimschi (15050880) (author), Mohamed E. Abazeed (14936313) (author)
Хэвлэсэн:	2025
Нөхцлүүд:	Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Genetic biomarkers Computational Methods Algorithms Gene Technologies Mutation detection methods Lung Cancer
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

Ижил төстэй зүйлс

Supplementary Data 1 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
-н: Priyanka Gopal (15050862)
Хэвлэсэн: (2025)

Supplementary Data 2 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
-н: Priyanka Gopal (15050862)
Хэвлэсэн: (2025)

Supplementary Data 3 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
-н: Priyanka Gopal (15050862)
Хэвлэсэн: (2025)

Supplementary Data 4 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
-н: Priyanka Gopal (15050862)
Хэвлэсэн: (2025)

Supplementary Data 5 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
-н: Priyanka Gopal (15050862)
Хэвлэсэн: (2025)

Supplementary Figure S6 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
-н: Leon J. Wils (15055780)
Хэвлэсэн: (2025)

Supplementary Table S7 from Gene Fusion Detection and Characterization in Long-Read Cancer Transcriptome Sequencing Data with FusionSeeker
-н: Yu Chen (14962271)
Хэвлэсэн: (2025)

Supplementary Figure S1 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
-н: Leon J. Wils (15055780)
Хэвлэсэн: (2025)

Supplementary Figure S10 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
-н: Leon J. Wils (15055780)
Хэвлэсэн: (2025)

Supplementary Figure S11 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
-н: Leon J. Wils (15055780)
Хэвлэсэн: (2025)

Supplementary Figure S12 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
-н: Leon J. Wils (15055780)
Хэвлэсэн: (2025)

Supplementary Figure S2 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
-н: Leon J. Wils (15055780)
Хэвлэсэн: (2025)

Supplementary Figure S4 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
-н: Leon J. Wils (15055780)
Хэвлэсэн: (2025)

Supplementary Figure S5 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
-н: Leon J. Wils (15055780)
Хэвлэсэн: (2025)

Supplementary Figure S7 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
-н: Leon J. Wils (15055780)
Хэвлэсэн: (2025)

Supplementary Figure S8 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
-н: Leon J. Wils (15055780)
Хэвлэсэн: (2025)

Supplementary Figure S9 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
-н: Leon J. Wils (15055780)
Хэвлэсэн: (2025)

Supplementary Table S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
-н: Aleksandar Obradovic (7549517)
Хэвлэсэн: (2025)

Supplementary Table S2 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
-н: Aleksandar Obradovic (7549517)
Хэвлэсэн: (2025)

Supplementary Figure S1 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study
-н: Joel R. Eisner (15132120)
Хэвлэсэн: (2025)

Supplementary Figure S2 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study
-н: Joel R. Eisner (15132120)
Хэвлэсэн: (2025)

Supplementary Table S2 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study
-н: Joel R. Eisner (15132120)
Хэвлэсэн: (2025)

Figure S1 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
-н: Subhamoy Chakraborty (16648124)
Хэвлэсэн: (2025)

Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
-н: Subhamoy Chakraborty (16648124)
Хэвлэсэн: (2025)

Figure S3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
-н: Subhamoy Chakraborty (16648124)
Хэвлэсэн: (2025)

Supplementary Tables 1-3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
-н: Subhamoy Chakraborty (16648124)
Хэвлэсэн: (2025)

Figure 6 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
-н: Tobias Kessler (17079209)
Хэвлэсэн: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
-н: Lavanya Sivapalan (15314248)
Хэвлэсэн: (2025)

Supplementary Tables S1-S10 from <i>ACTA2</i> Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer
-н: Sunho Park (15053897)
Хэвлэсэн: (2025)

Figure 1 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Figure 3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Figure 4 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Figure 5 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Supplementary Table S1-S3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
-н: David Milewski (15050643)
Хэвлэсэн: (2025)

Supplementary Figure S1 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
-н: Tobias Kessler (17079209)
Хэвлэсэн: (2025)

Supplementary Figure S2 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
-н: Tobias Kessler (17079209)
Хэвлэсэн: (2025)

Supplementary Figure S3 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
-н: Tobias Kessler (17079209)
Хэвлэсэн: (2025)

Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
-н: Tobias Kessler (17079209)
Хэвлэсэн: (2025)

Cannot write session to /tmp/vufind_sessions/sess_1od59k7tarm1sg98id4a21opup